Ethic Inc. Repligen Corp Transaction History

Ethic Inc.

$3.97 Billion
Q3 2024

A detailed history of Ethic Inc. transactions in Repligen Corp stock. As of the latest transaction made, Ethic Inc. holds 1,663 shares of RGEN stock, worth $207,425. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,663

Holding current value

$207,425

% of portfolio

0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$119.79 - $167.35 $199,210 - $278,303	1,663 New	1,663 $247,000
Q1 2024 May 13, 2024	SELL	$170.78 - $208.42 $2,732 - $3,334	-16 Reduced 0.95%	1,663 $305,000
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $20,436 - $33,177	179 Added 11.93%	1,679 $301,000
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $98,117 - $124,792	-707 Reduced 32.03%	1,500 $238,000
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $78,068 - $101,694	-564 Reduced 20.35%	2,207 $312,000
Q1 2023 May 12, 2023	BUY	$154.26 - $198.1 $5,090 - $6,537	33 Added 1.21%	2,771 $466,000
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $70,327 - $95,502	-433 Reduced 13.65%	2,738 $463,000
Q3 2022 Nov 14, 2022	BUY	$160.42 - $256.21 $123,202 - $196,769	768 Added 31.96%	3,171 $593,000
Q2 2022 Aug 10, 2022	SELL	$140.68 - $188.02 $21,946 - $29,331	-156 Reduced 6.1%	2,403 $390,000
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $97,842 - $156,581	607 Added 31.1%	2,559 $481,000
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $17,826 - $21,921	72 Added 3.83%	1,952 $517,000
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $92,126 - $153,351	473 Added 33.62%	1,880 $543,000
Q2 2021 Aug 10, 2021	BUY	$165.87 - $220.95 $233,379 - $310,876	1,407 New	1,407 $281,000

Others Institutions Holding RGEN

# of Institutions

487

Shares Held

54.4M

Call Options Held

341K

Put Options Held

235K

Black Rock Inc. New York, NY

7.57M
Shares

$944 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

6.39M
Shares

$797 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

5.04M
Shares

$629 Million
0.01% of portfolio
State Street Corp Boston, MA

1.62M
Shares

$203 Million
0.01% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.42M
Shares

$177 Million
1.34% of portfolio

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account